论文部分内容阅读
目的:探讨基于智能疾病管理系统（SSDM）对类风湿关节炎患者心理状况、自我效能以及活动度的影响。方法:选取2019年5月至12月于东莞东华医院治疗的类风湿关节炎患者115例。脱组3例，最终纳入112例患者，其中男60例，女52例，年龄23～76岁。采用随机数字表法分为对照组与研究组，对照组应用常规教育+电话随访教育，研究组在此基础上应用基于智能疾病管理系统对患者进行管理。观察两组的疾病活动性评分28（DAS28）、健康评估问卷（HAQ）评分、健康调查简表（SF-36）评分、汉密尔顿抑郁量表（HAMD）评分、汉密尔顿焦虑量表（HAMA）评分、晨僵时间、疾病缓解率、随访率以及复发率。应用SPSS 20.0进行数据分析，采用n χ2检验、n t检验。n 结果:干预后，研究组DAS28、HAQ、HAMD、HAMA评分均比对照组低（均n P<0.05）；干预后，研究组SF-36评分比对照组高（n P<0.05）。干预后，研究组晨僵时间较对照组缩短（n P<0.05）；研究组缓解率为98.21%（55/56），随访率为96.43%（54/56），显著高于对照组的83.93%（47/56）、80.36%（45/56），复发率为1.79%（1/56），显著低于对照组的16.07%（9/56），差异均有统计学意义（n χ2=6.245、6.527、10.721，n P=0.008、=0.006、<0.001）。n 结论:类风湿关节炎患者在疾病治疗过程中应用智能疾病管理系统效果更佳，可以有效改善患者的生活质量，调整患者的不良心理状况，有效的降低疾病活动度，同时可以提高疾病的缓解率以及患者随访率，降低疾病复发率，在类风湿关节炎患者的疾病管理中值得推广和应用。“,”Objective:To explore the impact of the Smart System of Disease Management (SSDM) on the psychological status, self-efficacy, and mobility of patients with rheumatoid arthritis.Methods:One hundred and fifteen patients with rheumatoid arthritis who were treated in Dongguan Tungwah Hospital from May to December 2019 were selected. Three patients were removed from the group, and 112 patients were finally included, including 60 males and 52 females who were 23-76 years old. They were divided into a control group and a research group by the random number table method. The control group took routine education and telephone follow-up education. On this basis, the research group applied SSDM to manage the patients. The scores of Disease Activity Score 28 (DAS28), Health Assessment Questionnaire (HAQ), health survey brief table (SF-36), Hamilton Depression Scale (HAMD), and Hamilton Anxiety Scale (HAMA), morning stiffness times, disease remission rates, follow-up rates, and relapse rates in these two groups were observed. SPSS 20.0 was used for the data analysis.n χ2 and n t tests were applied.n Results:After the intervention, the scores of DAS28, HAQ, HAMD, and HAMA were lower, the score of SF-36 was higher, and the morning stiffness time was shorter in the research group than in the control group (all n P<0.05). The remission rate, the follow-up rate, and the recurrence rate were 98.21% (55/56), 96.43% (54/56), 1.79% (1/56) in the research group, and were 83.93% (47/56), 80.36% (45/56), and 16.07% (9/56) in the control group, with statistical differences (n χ2=6.245, 6.527, and 10.721; n P=0.008, =0.006, and <0.001).n Conclusions:The SSDM for patients with rheumatoid arthritis is more effective in the course of disease treatment. It can effectively improve the patients\' quality of life, adjust their poor psychological conditions, effectively reduce the disease activity, and increase the disease remission rate and follow-up rate, and reduce the disease recurrence rate, so it is worthy of promotion and application in the disease management of patients with rheumatoid arthritis.